Review
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3798-3819
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3798
Table 1 Molecular mechanisms and clinical effects of traditional Chinese medicine formulas and plant components
TCM formulas
Plant components
Clinical studies outcome
In vitro studies outcome
Key molecular targets
Molecular mechanisms
Banxia Xiexin DecoctionPinellia ternata, coptis chinensis, scutellaria baicalensis-Inhibits proliferation, invasion, metastasis of GC cellsWnt/β-catenin, PD-L1, HIF-1, EGFR, TLR4Inhibits Wnt/β-catenin pathway, induces oxidative stress, modulates apoptosis
Sijunzi DecoctionPanax ginseng, Atractylodes macro cephala, Poria cocos, Glycyrrhiza uralensisEnhances immune function, improves nutritional status in GC patientsAffects cell lines like MKN-28 and HGC-27TNF-α, IL-6, TP53, JUN, VEGFA, PI3K/AKTRegulates PI3K/AKT pathway, induces apoptosis, reduces tumor growth
Xiang-Sha-Liu-Jun-Zi-TangPanax ginseng, Poria cocos, Atractylodes macro cephala, Pinellia ternata, Citrus reticulata, Aucklandia lappa, Villous Amomum, Glycyrrhiza uralensisEnhances survival post-surgery and chemotherapy for GCPhytochemical study identified 144 active ingredientsTP53, MMP9, TIMP1, MYC, TNF, IL-17 signalingTargets TNF and IL-17 signaling pathways, induces apoptosis, inhibits proliferation
Jianpi Yangzheng Xiaozheng DecoctionAstragalus membranaceus, Codonopsis pilosula, Atractylodes macro cephala, Angelica sinensis, Paeonia lactiflora, Sparganium stoloniferum, Curcuma zedoaria, Citrus reticulata, Aucklandia lappa, Hedyotis diffusa, Salvia chinensis, Glycyrrhiza uralensisUsed in patients with advanced GCInhibits cancer cell proliferationPD-L1, IL-6/JAK2/STAT3Modulates immune response, decreases expansion of myeloid-derived suppressor cells
Shenqi Fuzheng FormulaRadix codonopsis, radix astragaliImproves quality of life and immune function in combination with chemotherapy-Not specified in detailEnhances immune function, reduces chemotherapy side effects, improves patient outcomes